PY

Priti Yadav

Active Director Director DIN 08792214
DIN 08792214 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Priti Yadav

Data last updated:

Priti Yadav is a Director at Medarx Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Medarx Pharmaceuticals Private Limited reported revenue of ₹9.7 Lakh (FY 2025).

DIN 08792214
Primary Designation Director
Industry Healthcare
First Appointment 13 Jul 2020
Oldest Company Age 6 yrs
Largest company Medarx Pharmaceuticals Private Limited · ₹9.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jul 20202020₹9.7 Lakh (FY 2025)Active

Board colleagues of Priti Yadav

NameDINCompanyDesignation
Pooja Maurya08792215Medarx Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medarx Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priti Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Yadav

Priti Yadav currently holds 1 directorship: Medarx Pharmaceuticals Private Limited (Director, since 13 Jul 2020, revenue ₹9.7 Lakh (FY 2025)).

Priti Yadav was first appointed on 13 Jul 2020 as Director at Medarx Pharmaceuticals Private Limited.

The current boards of Priti Yadav's companies include Pooja Maurya (Medarx Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available